About the Special Issue

Dear Colleagues,

The global prevalence of diabetes and related metabolic disorders, including obesity, continues to escalate, posing significant challenges to healthcare systems worldwide. These complex conditions often intertwine, contributing to a cascade of adverse health outcomes, such as cardiovascular disease, nephropathy, neuropathy, and certain cancers. While lifestyle interventions and existing pharmacological approaches offer some benefits, the need for more effective and targeted therapies remains critical. This special issue of Exploration of Endocrine and Metabolic Diseases will delve into innovative therapeutic and diagnostic strategies for diabetes and related metabolic disorders.  We aim to showcase cutting-edge research exploring the potential of novel approaches to address the multifaceted challenges associated with these conditions.  

This issue will encompass a broad spectrum of research, from fundamental studies elucidating the molecular mechanisms underlying metabolic dysfunction to translational investigations evaluating the safety and efficacy of emerging therapies. We encourage submissions that explore novel drug targets, innovative diagnostic biomarkers, and personalized management strategies. Areas of interest include, but are not limited to, investigations into novel therapeutic agents, advanced drug delivery systems, and the application of omics technologies for early disease detection and risk stratification. We are particularly interested in studies that explore the interplay between different metabolic pathways and the development of targeted interventions.

This special issue will serve as a valuable platform for researchers, clinicians, and industry professionals to share their latest findings, exchange ideas, and discuss future directions in the field. We anticipate that this collection of articles will stimulate further research and accelerate the translation of innovative strategies into effective solutions for the growing burden of diabetes and related metabolic disorders, ultimately improving patient outcomes and quality of life.

Dr Dawood Khan and Professor Victor Gault

Guest Editors

Keywords: diabetes; obesity; metabolic disorders; peptides; peptide therapeutics; peptide diagnostics; insulin resistance; glucose metabolism; energy balance; gut hormones; dual agonists; translational research; clinical trials; drug delivery; biomarkers

Call for Papers